Greenbrook TMS NeuroHealth Centers - Glen Allen

Greenbrook TMS NeuroHealth Centers - Glen Allen offers Transcranial Magnetic Stimulation (TMS) therapy and Spravato® nasal esketamine spray for the treatment of depression. TMS therapy is FDA-cleared and non-invasive, providing relief for Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD). Spravato® is an FDA-approved nasal esketamine spray tailored to combat depression, covered by most major insurance companies.

Glen Allen, with a population exceeding 16,000, now provides access to TMS therapy and nasal esketamine for those seeking alternatives to traditional treatments. The center ensures a comprehensive approach, offering consultations with the Care Team to determine personalized treatment plans. From insurance assistance to treatment initiation, Greenbrook Glen Allen remains committed to supporting individuals throughout their therapeutic journey.

Utilizing magnetic technology akin to MRI machines, TMS therapy targets mood-regulating brain regions, providing symptom relief for approximately 83% of patients unresponsive to antidepressants. Treatment typically spans six to nine weeks, with sessions lasting 18-45 minutes and no downtime post-treatment. The center's individualized approach tailors treatment plans to each patient's unique needs and responses.

Generated from the website content